马来酸依那普利

Name: 马来酸依那普利
Brand: 济南圣和化工有限公司

CAS 76095-16-4C24H32N2O9MW 492.5

本页收录马来酸依那普利，CAS 登记号为 76095-16-4，分子式 C24H32N2O9，分子量 492.5，归类于医药中间体及原料药。作为主营产品之一，济南圣和化工有限公司可提供从公斤级到吨级的稳定供货，随货附 COA 与质检资料。

产品概览

CAS号	76095-16-4
分子式	C24H32N2O9
分子量	492.5
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	医药中间体及原料药
类别	医药中间体及原料药

应用领域

医药中间体及原料药

马来酸依那普利在医药中间体及原料药领域使用广泛。采购前请确认纯度等级与包装形式，以批次 COA 为验收依据。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

采购提示：本产品按按订单/批次确认(不公开发布)起订发货，收到货物后请先核对包装完好性再行入库。储存条件为阴凉干燥、密封保存；如需 MSDS 或运输说明，可在询价时一并索取。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

济南圣和化工有限公司位于山东济南，主营化工原料供应，精选产品 3,000+ 种，覆盖有机化学品、无机化学品、食品添加剂、医药中间体等 12 大分类。我们随货提供 COA 分析证书，一个工作日内回复报价，欢迎国内外采购方长期合作。

常见问题

马来酸依那普利的 CAS 号是多少？

马来酸依那普利的 CAS 号为 76095-16-4。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

马来酸依那普利有什么用途？

主要应用于医药中间体及原料药。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Enalapril Maleate · CAS 76095-16-4 · C24H32N2O9. UNII 9O25354EPJ.

Identification

CAS Registry Number	76095-16-4
PubChem CID	5388961
Molecular formula	C24H32N2O9
IUPAC name	(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
UNII (FDA)	9O25354EPJ

Computed Descriptors

Molecular Weight	492.5
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	12
Exact Mass	492.21078060
Monoisotopic Mass	492.21078060
Topological Polar Surface Area	171
Heavy Atom Count	35
Formal Charge	0
Complexity	637

Physical description & handling notes

186.6 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Regulatory Status

GHS notification summary	1% (2 / 202)

GHS Hazard Classification

GHS notification summary	1% (2 / 202)
Reported hazard statements	H302 (19.3%), H318 (46%), H319 (23.3%), H360 (24.3%), H361 (36.1%), H362 (14.4%), H372 (18.3%)

This chemical does not meet GHS hazard criteria for 1% (2 of 202) of reports.

H302 (19.3%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors; ACE Inhibitors; ACEIs
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]; Angiotensin Converting Enzyme Inhibitor [EPC]
ENALAPRIL MALEATE ORAL SOLUTION
Angiotensin Converting Enzyme Inhibitor [EPC]; Decreased Blood Pressure [PE]; Angiotensin-converting Enzyme Inhibitors [MoA]

Synonyms

Enalapril maleate; 76095-16-4; Glioten; Renitec; Vasotec; Naprilene; Xanef; Hipoartel; Innovace; Amprace; Enacard; Enapren; Reniten; Pres; Ednyt; Epaned

Frequently Asked Questions

What are the CAS number and molecular formula of Enalapril Maleate?

CAS 76095-16-4; molecular formula C24H32N2O9; molecular weight — g/mol.

What other names is Enalapril Maleate known by?

Enalapril maleate, 76095-16-4, Glioten, Renitec, Vasotec, Naprilene.

Is Enalapril Maleate classified as hazardous?

1% of GHS notifications report no hazard classification (2 of 202).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.